Association Between Vitamin D Deficiency and Systemic Outcomes in Patients with Glaucoma: A Real-World Cohort Study
Open Access
Abstract
Background: Glaucoma is an age-related optic neuropathy frequently accompanied by systemic comorbidities. Vitamin D deficiency (VDD) has been associated with cardiovascular and renal diseases in the general population, yet its relationship with long-term systemic outcomes in glaucoma remains unclear. This study evaluated the association between baseline vitamin D status and subsequent mortality and cardiorenal events in patients with primary glaucoma. Methods: We conducted a retrospective cohort study using deidentified electronic health records from the TriNetX U.S. Collaborative Network, a federated network of participating healthcare organizations. Adults (≥18 years) with incident primary glaucoma (2005–2020) and a serum 25-hydroxyvitamin D (25(OH)D) test within 12 months prior to diagnosis were categorized as VDD (2). Analyses incorporated Kaplan–Meier curves, Cox models, landmark tests, sensitivity analyses, and competing risk methods. Results: Among the 35,100 eligible patients, the matched cohorts demonstrated higher 5-year risks associated with VDD for all-cause mortality (HR 1.104; 95% CI 1.001–1.217), MACE (HR 1.151; 95% CI 1.078–1.229), and AKI (HR 1.154; 95% CI 1.056–1.261), whereas the risks of renal function decline did not differ (HR 0.972; 95% CI 0.907–1.042). Risk divergence emerged within the first year of follow-up and persisted through the 5-year observation period. Conclusions: In patients with primary glaucoma, vitamin D deficiency was associated with higher long-term risks of mortality and cardiorenal complications, but not renal function decline. Taken together, the results are consistent with vitamin D status serving as a marker of broader systemic vulnerability in glaucoma and highlight the need for prospective studies to further clarify its prognostic significance.Keywords
This publication has 46 references indexed in Scilit:
- Relationships Among Glaucoma, Cardiovascular Diseases, and MortalityAdvances in Therapy, 2025
- Association of serum 25-hydroxyvitamin D with cardiovascular and all-cause mortality in patients with chronic kidney disease: NHANES 2007‒2018 resultsClinics, 2024
- Bidirectional association between glaucoma and chronic kidney disease: A systematic review and meta-analysiseClinicalMedicine, 2022
- 1α,25-dihydroxyvitamin D3 attenuates oxidative stress-induced damage in human trabecular meshwork cells by inhibiting TGFβ-SMAD3-VDR pathwayBiochemical and Biophysical Research Communications, 2019
- Is primary open-angle glaucoma an ocular manifestation of systemic disease?Graefe's Archive for Clinical and Experimental Ophthalmology, 2019
- Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040Ophthalmology, 2014
- Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health?European Journal of Epidemiology, 2014
- Vitamin D: a pleiotropic hormoneKidney International, 2010
- Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressureThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Expression of 1,25-Dihydroxyvitamin D3 Receptor in the Immune SystemArchives of Biochemistry and Biophysics, 2000